Wealth Quarterback LLC Cara Therapeutics, Inc. Transaction History

Wealth Quarterback LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $2,093 - $3,889	-281 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$12.38 - $29.19 $3,478 - $8,202	281 New	281 $5,000
Q2 2020 Aug 17, 2020	SELL	$12.39 - $17.33 $3,481 - $4,869	-281 Closed	0 $0
Q4 2019 Feb 27, 2020	SELL	$16.11 - $25.98 $2.27 Billion - $3.66 Billion	-140,754,828 Reduced 100.0%	281 $4,000
Q4 2019 Feb 18, 2020	BUY	$16.11 - $25.98 $2.27 Billion - $3.66 Billion	140,755,109 New	140,755,109 $2.27 Billion

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $24.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.